03 November 2003
The influence of glimepiride on the oxidative state of rats with streptozotocin-induced hyperglycemia
Hanna Krauss, Jacek Koźlik, Marian Grzymisławski, Przemysław Sosnowski, Kinga Mikrut, Jacek Piątek, Janusz PaluszakMed Sci Monit 2003; 9(11): BR389-393 :: ID: 13276
Abstract
Background:The aim of this work was to determine whether glimepiride, a derivate of sulphonylurea of the hypoglycemic effect, influences the level of prooxidative factors and antioxidative enzymes activity in the course of experimental streptozotocin hyperglycemia in rats.Material/Methods:The studies were performed on healthy male Wistar rats of body weight 200±30 g, fed with the standard laboratory diet and given water ad libitum. Animals were divided into 3 groups, each consisting of 8 rats. Group I – control animals, Group II – animals in which experimental hyperglycemia was induced by intraperitoneal administration of streptozotocin (65 mg/kg body mass), Group III – animals which were given glimepiride orally for seven weeks (200 mg/kg of body mass), starting 24 hours after streptozotocin administration. Using Ohkawa method, malondialdehyde level was determined in plasma for all groups. Concentration of hydrogen peroxide was determined using method developed by Frew and co-workers, superoxide dismutase activity using the Misra and Fridovich method and activity of glutathione peroxidase by means of Ransel kit [Randox, Great Britain]. The decrease of glucose level in serum of rats under the influence of streptozotocin and glimepiride was observed when compared with the group given placebo.Results:Glimepiride administration caused a decrease of peroxides and malondialdehyde levels and increase in activity of superoxide dismutase and glutathione peroxidase in rats, after streptozotocin had been administered.Conclusions:The results suggest that glimepiride may effectively inhibit the development of the oxidative stress in diabetes.
Keywords: Antioxidants - pharmacology, Body Weight, Glutathione - metabolism, Hyperglycemia - chemically induced, Hypoglycemic Agents - pharmacology, Malondialdehyde - metabolism, Oxygen - metabolism, Peroxides - metabolism, Rats, Wistar, Streptozocin - pharmacology, Sulfonylurea Compounds - pharmacology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952